8 pending office actions • 3 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Celularity Inc. | 6 |
| Sorrento Therapeutics, Inc. | 1 |
| Celularity Inc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18056088 | NATURAL KILLER CELLS AND ILC3 CELLS AND USES THEREOF | Celularity Inc. | DIBRINO, MARIANNE | 1641 | Non-Final OA | Nov 16, 2022 |
| 17998199 | PLACENTA-DERIVED ADHERENT (PDA) STEM CELL FOR THE TREATMENT OF ADULTS WITH SARS-COV-2 RELATED ACUTE RESPIRATORY FAILURE AND ARDS (COVID-19) | Celularity Inc. | VAN BUREN, LAUREN K | 1638 | Non-Final OA | Nov 08, 2022 |
| 18048291 | ENHANCED PLACENTAL STEM CELLS AND USES THEREOF | Celularity Inc. | TAKENAKA, RISA | 1632 | Final Rejection | Oct 20, 2022 |
| 17830865 | PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF | Sorrento Therapeutics, Inc. | CHATTIN, AMY MARIE | 1643 | Final Rejection | Jun 02, 2022 |
| 17619242 | POPULATIONS OF NATURAL KILLER CELLS FOR TREATING CANCERS | Celularity Inc. | BARRON, SEAN C | 1653 | Non-Final OA | Dec 14, 2021 |
| 17439671 | PLACENTA DERIVED ADHERENT CELLS FOR IMPROVED XENOPLANTATION | Celularity Inc. | MIANO, JOSEPH PAUL | 1631 | Final Rejection | Sep 15, 2021 |
| 17309451 | PLACENTA-DERIVED ALLOGENEIC CAR-T CELLS AND USES THEREOF | Celularity Inc. | TIWARI, VYOMA SHUBHAM | 1634 | Non-Final OA | May 27, 2021 |
| 17302353 | DEVICES AND METHODS FOR THAWING BIOLOGICAL MATERIAL | Celularity Inc. | KRCHA, MATTHEW D | 1796 | Final Rejection | Apr 30, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial